Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol

Clinical guidelines are developed by a thorough evaluation of available evidence on a certain drug, treatment, or medical condition; the results of this evaluation can be presented in many different ways to those involved in clinical guideline development groups (e.g., doctors, researchers, patients.) This protocol describes the plan for how we will search for, collect, and combine data from different types of studies to try to identify the best way to present the evidence to clinical guideline development groups. 

Date of publication: 10 May 2022
Authors: Melissa K Sharp, Barrie Tyner, Dayang Anis Binti Awang Baki, Cormac Farrell, Declan Devane, Kamal Mahtani, Susan M. Smith, Mairin Ryan, Michelle O’Neill, Barbara Clyne.
Journal: HRB Open Research
Digital object identifier: 10.12688/hrbopenres.13325.2
Type of output: Protocol
Suggested Citation:

Sharp MK, Tyner B, Awang Baki DAB, Farrell C, Devane D, Mahtani K, Smith SM, O'Neill M, Ryan M & Clyne B. 2021. Evidence synthesis summary formats for clinical guideline development group members: a mixed-methods systematic review protocol. HRB Open Research, 4, p.76 [version 2; peer review: 2 approved].